对m6A调节基因的分析和在心房的亚型分类
Yingliang Zhao1,2, Yanyun Che1,2, Qiming Liu1
1Department of Cardiovascular Medicine, Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Frontiers in cellular neuroscience
|July 12, 2023
概括
这项研究揭示了N6-甲基氨酸 (m6A) 调节基因在心房动 (AF) 中至关重要. 使用五个关键m6A基因的预测模型可以识别AF风险,帮助患者分类和治疗策略.
科学领域:
- 生物医学研究的研究.
- 遗传学 是一个遗传学.
- 心血管疾病是什么心血管疾病
背景情况:
- 心房动 (AF) 是一种常见的心律失常,具有复杂的潜在机制.
- N6-甲基氨酸 (m6A) 修饰是一种关键的表观遗传调节剂,在各种疾病中发挥着新兴的作用,包括心血管疾病.
研究的目的:
- 研究m6A调节基因在心房动 (AF) 病变发生和分类中的作用.
- 开发基于m6A相关基因表达的AF发病率预测模型.
- 为了识别AF患者的不同基于m6A的亚型.
主要方法:
- 利用基因表达综合 (GEO) 数据集来分析m6A调节基因表达在AF和鼻节律 (SR) 样本中的情况.
- 采用随机森林 (RF) 和支持矢量机 (SVM) 模型来识别特征基因.
- 使用显著的m6A调节基因用于AF预测,构建了一个名录模型.
- 根据基因表达差异和m6A分数将AF患者分为亚型.
主要成果:
- 确定了五个关键的m6A调节基因 (ZC3H13,YTHDF1,HNRNPA2B1,IGFBP2,IGFBP3) 预测AF发生率 (p <0.05).
- 使用射频开发了一个名ogram模型,可以准确预测AF风险.
- 发现了两种不同的m6A亚型和两种m6A基因亚型,在免疫细胞透和m6A分数 (p <0.05) 中存在显著差异.
- 在m6A亚型和m6A基因亚型之间显示出很高的一致性.
结论:
- m6A调节基因在心房动中起着重要作用.
- 开发的诺莫格拉姆模型为预测AF发生率提供了一个潜在的工具.
- 鉴定到的m6A修饰模式为AF患者的分类和指导个性化治疗策略提供了新的见解.
相关概念视频
Dysrhythmias II: Classification of Tachyarrhythmias
12
Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
12
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
48
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
48
Cardiomyopathy I: Introduction and Classification
19
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
19


